Market revenue in 2023 | USD 15.8 million |
Market revenue in 2030 | USD 32.2 million |
Growth rate | 10.7% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.86% in 2023. Horizon Databook has segmented the Switzerland pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Switzerland is a globally renowned hub of innovative research. It is highly competitive and dynamic in research activities. The demand for pharmaceutical sterility testing is often related to the growth of the biopharmaceutical industry.
Switzerland has a strong pharmaceutical and biotech sector, and if there is a continued increase in the development of biopharmaceuticals, it could drive demand for pharmaceutical sterility testing.
Many pharmaceutical and biotechnology companies outsource their sterility testing needs to specialized service providers. The outsourcing trend may continue, providing opportunities for service providers in Switzerland.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account